- Home
- VPG vs FDMT Comparison
VPG vs FDMT Comparison
Compare VPG & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPG
- FDMT
- Stock Information
- Founded
- VPG 2009
- FDMT 2013
- Country
- VPG United States
- FDMT United States
- Employees
- VPG N/A
- FDMT N/A
- Industry
- VPG Electrical Products
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- VPG Technology
- FDMT Health Care
- Exchange
- VPG Nasdaq
- FDMT Nasdaq
- Market Cap
- VPG 427.5M
- FDMT 391.8M
- IPO Year
- VPG N/A
- FDMT 2020
- Fundamental
- Price
- VPG $37.46
- FDMT $11.50
- Analyst Decision
- VPG
- FDMT Strong Buy
- Analyst Count
- VPG 0
- FDMT 9
- Target Price
- VPG N/A
- FDMT $30.11
- AVG Volume (30 Days)
- VPG 141.2K
- FDMT 933.7K
- Earning Date
- VPG 11-04-2025
- FDMT 11-07-2025
- Dividend Yield
- VPG N/A
- FDMT N/A
- EPS Growth
- VPG N/A
- FDMT N/A
- EPS
- VPG N/A
- FDMT N/A
- Revenue
- VPG $295,282,000.00
- FDMT $33,000.00
- Revenue This Year
- VPG N/A
- FDMT $9,656.76
- Revenue Next Year
- VPG $5.40
- FDMT N/A
- P/E Ratio
- VPG N/A
- FDMT N/A
- Revenue Growth
- VPG N/A
- FDMT N/A
- 52 Week Low
- VPG $18.57
- FDMT $2.24
- 52 Week High
- VPG $38.90
- FDMT $12.34
- Technical
- Relative Strength Index (RSI)
- VPG 60.16
- FDMT 63.45
- Support Level
- VPG $35.51
- FDMT $11.09
- Resistance Level
- VPG $38.90
- FDMT $12.34
- Average True Range (ATR)
- VPG 1.99
- FDMT 0.90
- MACD
- VPG 0.14
- FDMT 0.01
- Stochastic Oscillator
- VPG 78.60
- FDMT 71.43
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.